HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,428,680 | +2.9% | 37,400 | -2.9% | 0.03% | +6.5% |
| Q2 2023 | $1,388,695 | +1.3% | 38,500 | +7.2% | 0.03% | -11.4% |
| Q1 2023 | $1,371,021 | +66454.4% | 35,900 | -0.8% | 0.04% | -37.5% |
| Q4 2022 | $2,060 | -99.9% | 36,200 | -1.4% | 0.06% | +33.3% |
| Q3 2022 | $1,451,000 | -19.9% | 36,700 | +1.4% | 0.04% | -12.5% |
| Q2 2022 | $1,812,000 | +13.4% | 36,200 | -1.9% | 0.05% | +26.3% |
| Q1 2022 | $1,598,000 | +9.8% | 36,900 | +1.9% | 0.04% | +18.8% |
| Q4 2021 | $1,456,000 | -1.4% | 36,200 | -0.3% | 0.03% | -11.1% |
| Q3 2021 | $1,477,000 | -6.3% | 36,300 | +4.6% | 0.04% | -5.3% |
| Q2 2021 | $1,576,000 | +14.5% | 34,700 | +5.2% | 0.04% | +5.6% |
| Q1 2021 | $1,376,000 | +1.3% | 33,000 | +3.8% | 0.04% | -7.7% |
| Q4 2020 | $1,358,000 | – | 31,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |